Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Melanocortin 1 Receptor”

6 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 6 of 6 results

Testing effectiveness (Phase 2)Looking for participantsNCT05655312
What this trial is testing

MC1R-targeted Alpha-particle Monotherapy and Combination Therapy Trial With Nivolumab in Adults With Advanced Melanoma

Who this might be right for
Recurrent Melanoma (Skin)Metastatic MelanomaMelanoma Stage IV+1 more
Perspective Therapeutics 300
Large-scale testing (Phase 3)Study completedNCT02896192
What this trial is testing

Setmelanotide for the Treatment of Early-Onset Pro-Opiomelanocortin (POMC) Deficiency Obesity

Who this might be right for
Pro-opiomelanocortin (POMC) Deficiency Obesity
Rhythm Pharmaceuticals, Inc. 15
Not applicableNot Yet RecruitingNCT07815431
What this trial is testing

MC1R Mutations Associated With Red Hair and Perioperative Anesthesia Complications

Who this might be right for
Anaesthesia ComplicationPerioperative Adverse EventsRed Hair+1 more
Uppsala University 100,000
Large-scale testing (Phase 3)Study completedNCT03287960
What this trial is testing

Setmelanotide for the Treatment of Leptin Receptor (LEPR) Deficiency Obesity

Who this might be right for
Leptin Receptor Deficiency Obesity
Rhythm Pharmaceuticals, Inc. 15
Early research (Phase 1)Active Not RecruitingNCT05496686
What this trial is testing

Targeted Alpha Particle Radiotherapy for Metastatic Uveal Melanoma

Who this might be right for
Uveal MelanomaMetastatic
Modulation Therapeutics, Inc. 16
Early research (Phase 1)Study completedNCT04904120
What this trial is testing

Targeted Imaging of Melanoma for Alpha-Particle Radiotherapy

Who this might be right for
Melanoma (Skin)Melanoma Stage IVMelanoma, Uveal+1 more
Perspective Therapeutics 7